<DOC>
	<DOCNO>NCT01694667</DOCNO>
	<brief_summary>The propose study internet-based , randomize , double-blind , placebo-controlled trial ass change hyperactivity child age five eight autism spectrum disorder ( ASD ) elevate level hyperactivity . In order answer question , study ass change hyperactivity measure Aberrant Behavior Checklist ( ABC ) child ASD elevate baseline level hyperactivity randomly assign use 1.3 gram omega-3 fatty acid daily compare placebo . The overwhelming majority study procedure , include recruitment , informed consent , assessment inclusion exclusion criterion , collection baseline outcome measure take place internet .</brief_summary>
	<brief_title>Omega-3 Fatty Acids Hyperactivity Treatment Autism Spectrum Disorder</brief_title>
	<detailed_description>Families caregiver child enrol IAN Research age 5-8 establish diagnosis autism invite participate study e-mail . All family previously give consent contact research opportunity . Families respond e-mail recruitment letter undergo brief screen process determine child exclusion criterion ensure child age 5-8 , autism spectrum disorder , elevate baseline level hyperactivity . Families undergo on-line informed consent process include assent child . All participant give opportunity speak study team member question study informed consent process . Participants sign inform consent use electronic signature , process use previously IAN network approve John 's Hopkins Institutional Review Board ( IRB ) . Families meet eligibility criterion randomly assign mail study medication ( omega-3 placebo ) administer child parent twice daily six week . Both study medication match placebo orange-flavored pudding specifically design palatable young child . Assessment child hyperactivity , social functioning , overall disease severity measure baseline , three six week parent , complete on-line standard questionnaire ; ABC , Social Responsiveness Scale ( SRS ) , clinical Global Impressions Scale ( CGI ) . Side effect assess every week e-mail , report side effect immediately followed-up telephone contact PI . Although omega-3 fatty acid extremely safe prescribed dos , PI another study physician still call 24-hours-a-day , 7-days-a-week speak participant possible adverse event new medical problem ( enrolled family provide 24-hour emergency phone contact information ) . As part weekly e-mail reminder , parent also ask log medication provide child day previous week measure medication adherence .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<criteria>1 . Children participate Interactive Autism Network ( IAN ) Research Families 2 . Diagnosis ( Autism Spectrum Disorders ( ASD ) professional Social Communication Question ( SCQ ) score &gt; 12 3 . Age 58 4 . Aberrant Behavior Checklist Hyperactivity subscale ( ABCH ) &gt; 20 1 . Children foster care parent must affirm biological adoptive parent child 2 . Allergy fish 3 . Bleeding disorder , current use anticoagulant antiplatelet therapy , recent plan surgery 4 . Any major medical illness interferes regular school attendance 5 . Current recent ( past six month ) use omega3 fatty acid 6 . Siblings ASD</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>